Lipella Pharmaceuticals, Inc. (LIPO)
0.1551
0.00 (0.00%)
USD |
OTCM |
Feb 19, 16:00
Lipella Pharmaceuticals EPS Diluted (Quarterly) : -0.2757 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.254M |
| Total Expenses (Quarterly) | 1.254M |
| Enterprise Value | -0.875M |
| Earnings Yield | -1.55K% |
| Normalized Earnings Yield | -1555.00 |